NCT01110902 Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder (MDD) Status COMPLETED Phase PHASE3
NCT01110889 Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder Status COMPLETED Phase PHASE3
NCT01109030 Pioglitazone as an Adjunct for Moderate to Severe Depressive Disorder Status COMPLETED Phase PHASE2/PHASE3
NCT01103271 Pilot Study of Open-label Placebo to Treat Major Depressive Disorder Status COMPLETED Phase PHASE2
NCT01101373 Treatment of Severe Depressive Illness by Targeted Brain Surgery Status COMPLETED Phase N/A
NCT01098240 A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major Depression Status TERMINATED Phase PHASE2
NCT01085812 Relapse-Prevention Study With Levomilnacipran ER (F2695 SR) in Patients With Major Depressive Disorder Status COMPLETED Phase PHASE3
NCT01078948 Transcranial Direct Current Stimulation (tDCS) in the Treatment of Major Depressive Disorder (MDD) Status COMPLETED Phase NA
NCT01070329 A Study in Depression and Associated Painful Physical Symptoms Status COMPLETED Phase PHASE4
NCT01070134 Mindfulness-based Behavioural Therapy (MIBT) Versus Psychodynamic Therapy for Patients With Major Depressive Disorder in Psychotherapeutic Day Treatment. A Randomised Clinical Pilot Trial Status UNKNOWN Phase NA
NCT01056289 Study Comparing Discontinuation Symptoms Of DVS SR In Subjects With Major Depressive Disorder (MDD) Status COMPLETED Phase PHASE4
NCT01052077 Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder Status COMPLETED Phase PHASE2
NCT01035073 Functional Change and Efficacy of Duloxetine in Patients With Co-Morbid Depression & Soft Tissue Discomfort Syndrome Status COMPLETED Phase PHASE4
NCT01034462 Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder Status COMPLETED Phase PHASE3